Other
Antibiotic medicaments in measured doses, retail packs
HSN 3004 20 49 (Other antibiotic medicaments) is subject to drug import registration and licensing under the Drugs and Cosmetics Act, 1940, with the Central Drugs Standard Control Organisation (CDSCO) registration certificate and import licence as the binding pre-clearance requirements. The Directorate General of Foreign Trade (DGFT) classifies this tariff line under a restricted import policy with prohibition on oxytocin imports and a carve-out permitting oxytocin reference standards exclusively for test and analysis under a DCGI-issued test licence.
- Registration certificate from CDSCO
- Import licence from CDSCO
- Batch release certificate from CDSCO
Procedural directions for customs clearance are issued by: Directorate General of Foreign Trade.
- 1Obtain a valid drug registration certificate (document code 101dc1) and import licence for drugs (document code 9111dc) from the Central Drugs Standard Control Organisation before shipment. Ensure the registration covers the specific antibiotic formulation being imported; an import licence covering a different formulation or strength does not extend to this product.Drugs and Cosmetics Act, 1940 · document codes 101dc1 and 9111dc
- 2Upload all five mandatory documents in e-Sanchit at the bill of entry before out-of-charge: Certificate of Analysis — Drug (0010dc), Batch Release Certificate (0030dc), Label of Consignment (0110dc), Registration Certificate — Drugs (101dc1), and Import Licence for Drugs (9111dc). Any missing upload results in detention pending PGA-routed NOC verification.CBIC e-Sanchit PGA-facilitated bill requirement · document codes 0010dc, 0030dc, 0110dc, 101dc1, 9111dc
- 3If the consignment contains oxytocin (in any form other than reference standards for test and analysis), treat the import as prohibited. For oxytocin reference standards, the DCGI/CDSCO-issued test licence must be uploaded as supporting documentation and the restricted-import status declared on the bill of entry.S.O. 2357(E) dated 23-05-2022 · DGFT Notification 09/2015-2020 dated 23-05-2022
The most common error on this residual antibiotic tariff line is filing under the broad 3004 20 49 residual code without ensuring the CDSCO registration certificate precisely matches the imported formulation — a certificate issued for a branded or innovator product does not cover a parallel-imported or differently-branded variant of the same active ingredient. A mismatch between the registered product name and the import consignment description is treated as importation of an unregistered drug, attracting seizure and prosecution under the Drugs and Cosmetics Act, 1940, irrespective of whether the active antibiotic is otherwise licensed.